PSOM Update: Funding Opportunities

Updated RPPR Instruction Guide Available

Hot off the presses this fall, an updated Research Performance Progress Report (RPPR) Instruction Guide is now available. The instruction guide reflects progress reporting requirements for the Data Management and Sharing Plan, updated screenshots of the system, and other changes. Learn more on the Research Performance Progress Report (RPPR) page.

Please direct inquiries to: eRA Communications Team

The Leukemia & Lymphoma Society Career Development Program is Now Open!

Eligibility Phase deadline: October 18, 2024

The Leukemia & Lymphoma Society supports talented blood cancer researchers in the early phase of their careers through the Career Development Program. The CDP continues to provide a pool of dedicated researchers to advance the understanding and diagnosis of blood cancer, as well as the development of treatment and prevention options that will ultimately lead to a higher quality of life for blood cancer patients.

Sarcoidosis Grant Program Announcement for 2024

Letter of Intent deadline: October 23, 2024

The Milken Institute, in collaboration with the Ann Theodore Foundation, is launching the next cycle of a grant program focused on sarcoidosis. The program intends to fund up to 6 grants this cycle, awarding up to $575,000 over two years to support research focused on the basic science of sarcoidosis. A third year of funding may be available for eligible grantees. If you or researchers at your institution have additional questions, please visit our website or contact our team.

Please direct inquiries to: Sarcoidosis Grant Team

AHA - New Strategically Focused Research Network Funding-Cardiovascular Kidney Metabolic Syndrome: Heterogeneity in Women

Pre-Proposal deadline: October 30, 2024

The next AHA Strategically Focused Research Network (SFRN) will focus on Cardiovascular Kidney Metabolic (CKM) Syndrome in women. CKM Syndrome is a health disorder due to connections among heart disease, kidney disease, diabetes and obesity. The goal of the network will be to expand our understanding of heterogeneity of CKM in women and the related contributing factors. Outcomes from the SFRN should facilitate improved approaches for both prevention and treatment of CKM.

American Heart Association Funding Updates

Submission deadlines: Fall 2024

Submission deadlines have been set for several AHA research funding awards. Some programs require pre-proposals, which are mandatory. Details are available at the link below.

Kissick Family Foundation Announces Funding Opportunity in FTD

Letter of Intent deadline: November 1, 2024

The Milken Institute is excited to announce the launch of the second cycle of the Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program. The RFP calls for basic science or early-stage translational research projects that focus on building a fundamental understanding of sporadic FTD. The Kissick Family Foundation, with guidance from the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), welcomes proposals requesting up to $500K over 2 years.

Please direct inquiries to: Milken Institute

The Doris Duke Foundation Announces the Collective to Strengthen Pathways for Health Research

Submission deadline: November 8, 2024

The Collective is seeking to bring greater attention and resources to breakthrough health research to improve how we prevent and manage disease. We are now inviting organizations to re-imagine research for better health and consolidate a community at the vanguard of innovation. Selected organizations will each host a multi-sector symposium informed by the local health context.

Please direct inquiries to: Kevin Sia

New Open Call: Action for Women’s Health, a $250M Global Open Call

Submission deadline: December 3, 2024

Pivotal, a Melinda French Gates organization, launched Action for Women’s Health, a $250 million global open call that will fund organizations around the world that are improving women’s mental and physical health. Action for Women’s Health – managed in partnership with Lever for Change – will support organizations of diverse geographies, sizes, perspectives, and approaches that are united by their work to improve the mental and physical health of women.

Please direct inquiries to: Action for Women's Health

The Leukemia and Lymphoma Society (LLS) announces the opening of the Specialized Center of Research (SCOR) program

Submission deadline: December 6, 2024

Important: Because of particular contractual requirements, any faculty interested in applying should first seek approval by emailing Michael Ostap, interim Chief Scientific Officer, and Robert Vonderheide, Director of the Abramson Cancer Center. Careful consideration of proprietary information or potential IP from the proposed work is required; if there are specific questions about IP, please contact Benjamin Dibling, Managing Director of the Penn Center for Innovation.

Please direct inquiries to: Office of the CSO

2025 CSL Research Acceleration Initiative

Submission deadline: December 13, 2024

CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and global research organizations. These partnerships provide funding and access to industry experts for scientists working on novel biotherapeutic strategies in CSL’s therapeutic areas.

Please direct inquiries to: Lina Axonova

The Leukemia & Lymphoma Society Underrepresented Minority (URM) Medical Student Research Program is Open

Submission deadline: December 15, 2024

The Leukemia & Lymphoma Society (LLS) Underrepresented Minority (URM) Medical Student Research Program is open for applications through December 15, 2024, at 3 PM EST for the 2025-2026 academic year.

RNA Pilot Grant Program - Fall 2024 RFA

Submission deadline: October 25, 2024

The Penn Institute for RNA Innovation seeks to support RNA-related basic, translational and clinical research. Pilot funding will provide initial support to establish proof of concept or extend findings to enable extramural funding and publications in the future. The Fall 2024 Pilot Grant Program research priority area will be to support cross-disciplinary research that will lead to extramurally funded research in either Basic or Translational Science in the arena of RNA biology.

Please direct inquiries to: Jill Agolino

Draw Down the Lightning Grants

Submission deadline: October 28, 2024

Draw Down the Lightning grants seek to harness our collective innovation, collaboration, and creativity. Faculty, students, postdocs, and staff are invited to propose projects aligned with Penn’s mission and strategic framework, addressing important challenges of our time such as climate change; health; data & technology; truth and democracy; and community engagement. The topics are purposefully open-ended to encourage the widest range of ideas and new programs that will advance Penn’s mission.

Please direct inquiries to: Eugene Vaynberg

Penn Clinical and Translational Science KL2 Mentored Career Development Award (PI: Emma Meagher, MD)

Submission deadline: October 28, 2024

ITMAT Education is pleased to announce a request for applications to the Penn CTSA KL2 Mentored Career Development Award. This award seeks to support early career faculty focused on advancing Clinical and Translational Science (CTS).

Please direct inquiries to: Megan Maxwell

The Institute of Structural Biology 2025-2026 Pilot Grant Program

Submission deadline: December 1, 2024

The Institute of Structural Biology (ISB) announces its annual Pilot Grant Program in Structural Biology. The program aims to foster interdisciplinary collaboration and advance Structural Biology techniques. It promotes appreciation for Structural Biology in fundamental and translational biomedical science, building a community of users at UPenn through shared Core facilities. The grant requires collaboration between at least two investigators on interdisciplinary projects.

Please direct inquiries to: Camila Spaulonci

ARPA-H Launches Initiative for Emerging Health Innovators

Survey deadline: October 25, 2024

ARPA-H is launching the Emerging Health Innovators (EHI) Initiative to increase access to government research funding for early career researchers and community health innovators to address health care gaps in the U.S. The EHI Initiative begins with a Network Survey, which will gather information and insights from emerging health innovators about their specific needs, challenges, and concerns.

Please direct inquiries to: Office of the CSO

ARPA-H Launches New Funding Opportunity - CATALYST

Proposer's Day: October 29, 2024

ARPA-H just launched a new funding opportunity: CATALYST (Computational ADME-Tox and Physiology Analysis for Safer Therapeutics) program intends to create human physiology-based computer models to accurately predict safety and efficacy profiles for Investigational New Drug (IND) candidates. CATALYST seeks proposals across three technical areas, including data discovery and deep learning, living systems tools, and in silico models, to improve preclinical and clinical drug safety testing.

Please direct inquiries to: Office of the CSO

ARPA-H Announces New Funding Opportunity to Make AI-enabled Tools More Reliable

Submission deadline: January 15, 2025

ARPA-H has launched the PRECISE-AI (Performance and Reliability Evaluation for Continuous Modifications and Useability of Artificial Intelligence) program to ensure AI-enabled medical tools stay accurate and reliable over time. PRECISE-AI will hold a hybrid Proposers’ Day for all interested performers this fall. Stay up to date by visiting the PRECISE-AI program page (link below).

Please direct inquiries to: Office of the CSO

Submit to the Newsletter

PSOM newsletters share a range of resources – Don’t miss the latest edition of the PSOM Update: Faculty Newsletter